APROFORT
DCI : IRBESARTAN+AMLODIPINE
Dosage 150 mg/5 mg
Pharmaceutical form Coated tablet
Therapeutic class Cardiology-Engiology
P/30
Indications
Treatment of essential hypertension. APROFORT is indicated for patients whose blood pressure is not adequately controlled with ibesartan or amlodipine as monotherapy.
Download the leaflet
